Laudanno Om, Vasconcelos L, Catalana J, Cesolari Ja
Experimental Gastroenterology, School of Medical Sciences, Cochabamba 2090, 2000, Rosario, Argentina.
Dig Dis Sci. 2006 Dec;51(12):2180-3. doi: 10.1007/s10620-006-9175-4. Epub 2006 Nov 2.
The anti-inflammatory effect of Bioflora probiotic administered orally or subcutaneously with viable or nonviable bacteria was analyzed in two experimental models of randomly selected female Wistar rats. The use of indomethacin at a dose of 50 mg/kg was associated with gastric necrotic lesions and multiple erosions of the small intestine, with marked mucosal neutrophil infiltrate measured by myeloperoxidase (MPO). Probiotics prevented both gastrointestinal lesions and neutrophil infiltrate (p < 0.001). In the model of carrageenin-induced plantar edema in the rat, the oral or subcutaneous administration of Bioflora with live or dead bacteria proved to prevent plantar edema (p < 0.001). We concluded that Bioflora probiotic given orally or subcutaneously with live or dead bacteria has an anti-inflammatory effect.
在随机选取的雌性Wistar大鼠的两种实验模型中,分析了口服或皮下注射有活性或无活性细菌的Bioflora益生菌的抗炎作用。使用50mg/kg剂量的吲哚美辛会导致胃坏死性病变和小肠多处糜烂,并通过髓过氧化物酶(MPO)检测到明显的黏膜中性粒细胞浸润。益生菌可预防胃肠道病变和中性粒细胞浸润(p<0.001)。在大鼠角叉菜胶诱导的足跖水肿模型中,口服或皮下注射有活性或无活性细菌的Bioflora可预防足跖水肿(p<0.001)。我们得出结论,口服或皮下注射有活性或无活性细菌的Bioflora益生菌具有抗炎作用。